SI1265873T1 - 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents - Google Patents
4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agentsInfo
- Publication number
- SI1265873T1 SI1265873T1 SI200130046T SI200130046T SI1265873T1 SI 1265873 T1 SI1265873 T1 SI 1265873T1 SI 200130046 T SI200130046 T SI 200130046T SI 200130046 T SI200130046 T SI 200130046T SI 1265873 T1 SI1265873 T1 SI 1265873T1
- Authority
- SI
- Slovenia
- Prior art keywords
- cinnolinecarboxamides
- dihydro
- oxo
- antiviral agents
- antiviral
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19129100P | 2000-03-21 | 2000-03-21 | |
PCT/US2001/005811 WO2001070706A2 (en) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
EP01920138A EP1265873B1 (de) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarbonsäure-amide als antivirusmittel |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1265873T1 true SI1265873T1 (en) | 2004-02-29 |
Family
ID=22704885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200130046T SI1265873T1 (en) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
Country Status (28)
Country | Link |
---|---|
US (1) | US6624160B2 (de) |
EP (1) | EP1265873B1 (de) |
JP (1) | JP2003528087A (de) |
KR (1) | KR20020081479A (de) |
CN (1) | CN1406228A (de) |
AR (1) | AR027978A1 (de) |
AT (1) | ATE252086T1 (de) |
AU (1) | AU2001247224A1 (de) |
BR (1) | BR0109487A (de) |
CA (1) | CA2400000A1 (de) |
CZ (1) | CZ20023141A3 (de) |
DE (1) | DE60100999T2 (de) |
DK (1) | DK1265873T3 (de) |
EA (1) | EA200201002A1 (de) |
EE (1) | EE200200541A (de) |
ES (1) | ES2208581T3 (de) |
HK (1) | HK1052694A1 (de) |
HU (1) | HUP0300326A3 (de) |
IL (1) | IL151787A0 (de) |
MX (1) | MXPA02009251A (de) |
NO (1) | NO20024502L (de) |
NZ (1) | NZ521524A (de) |
PL (1) | PL357443A1 (de) |
PT (1) | PT1265873E (de) |
SI (1) | SI1265873T1 (de) |
SK (1) | SK12102002A3 (de) |
WO (1) | WO2001070706A2 (de) |
ZA (1) | ZA200207540B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20011349A1 (es) * | 2000-06-16 | 2002-01-19 | Upjohn Co | 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales |
US9505775B2 (en) | 2012-11-03 | 2016-11-29 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
CN112996789A (zh) | 2018-09-12 | 2021-06-18 | 诺华股份有限公司 | 抗病毒吡啶并吡嗪二酮化合物 |
AU2020353055B2 (en) | 2019-09-26 | 2024-03-07 | Gilead Sciences, Inc. | Antiviral pyrazolopyridinone compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8513639D0 (en) | 1985-05-30 | 1985-07-03 | Ici America Inc | Cinnoline compounds |
GB8702288D0 (en) | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
ES2211965T3 (es) | 1995-08-02 | 2004-07-16 | Darwin Discovery Limited | Quinolonas y su utilizacion terapeutica. |
ES2193252T3 (es) | 1995-08-02 | 2003-11-01 | Darwin Discovery Ltd | Quinolonas y su uso terapeutico. |
ATE303993T1 (de) | 1997-12-22 | 2005-09-15 | Pharmacia & Upjohn Co Llc | 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe |
HUP0002353A3 (en) | 1998-01-29 | 2001-11-28 | Daiichi Asubio Pharma Co Ltd | 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phoshodiesterase iv inhibitory activity and pharmaceutical compositions containing them |
-
2001
- 2001-03-15 WO PCT/US2001/005811 patent/WO2001070706A2/en active IP Right Grant
- 2001-03-15 SK SK1210-2002A patent/SK12102002A3/sk unknown
- 2001-03-15 EP EP01920138A patent/EP1265873B1/de not_active Expired - Lifetime
- 2001-03-15 US US09/808,836 patent/US6624160B2/en not_active Expired - Fee Related
- 2001-03-15 CA CA002400000A patent/CA2400000A1/en not_active Abandoned
- 2001-03-15 BR BR0109487-4A patent/BR0109487A/pt not_active IP Right Cessation
- 2001-03-15 AU AU2001247224A patent/AU2001247224A1/en not_active Abandoned
- 2001-03-15 AT AT01920138T patent/ATE252086T1/de not_active IP Right Cessation
- 2001-03-15 DK DK01920138T patent/DK1265873T3/da active
- 2001-03-15 PL PL01357443A patent/PL357443A1/xx not_active Application Discontinuation
- 2001-03-15 CZ CZ20023141A patent/CZ20023141A3/cs unknown
- 2001-03-15 EE EEP200200541A patent/EE200200541A/xx unknown
- 2001-03-15 MX MXPA02009251A patent/MXPA02009251A/es active IP Right Grant
- 2001-03-15 PT PT01920138T patent/PT1265873E/pt unknown
- 2001-03-15 CN CN01805756A patent/CN1406228A/zh active Pending
- 2001-03-15 HU HU0300326A patent/HUP0300326A3/hu unknown
- 2001-03-15 JP JP2001568916A patent/JP2003528087A/ja active Pending
- 2001-03-15 DE DE60100999T patent/DE60100999T2/de not_active Expired - Fee Related
- 2001-03-15 ES ES01920138T patent/ES2208581T3/es not_active Expired - Lifetime
- 2001-03-15 KR KR1020027012466A patent/KR20020081479A/ko not_active Application Discontinuation
- 2001-03-15 SI SI200130046T patent/SI1265873T1/xx unknown
- 2001-03-15 NZ NZ521524A patent/NZ521524A/en unknown
- 2001-03-15 EA EA200201002A patent/EA200201002A1/ru unknown
- 2001-03-15 IL IL15178701A patent/IL151787A0/xx unknown
- 2001-03-20 AR ARP010101303A patent/AR027978A1/es unknown
-
2002
- 2002-09-19 ZA ZA200207540A patent/ZA200207540B/en unknown
- 2002-09-20 NO NO20024502A patent/NO20024502L/no not_active Application Discontinuation
-
2003
- 2003-07-09 HK HK03104900.8A patent/HK1052694A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20020045619A1 (en) | 2002-04-18 |
PT1265873E (pt) | 2004-03-31 |
SK12102002A3 (sk) | 2003-03-04 |
MXPA02009251A (es) | 2004-04-05 |
DE60100999D1 (en) | 2003-11-20 |
HUP0300326A3 (en) | 2003-09-29 |
DK1265873T3 (da) | 2004-02-16 |
NZ521524A (en) | 2004-04-30 |
KR20020081479A (ko) | 2002-10-26 |
JP2003528087A (ja) | 2003-09-24 |
CZ20023141A3 (cs) | 2003-02-12 |
EA200201002A1 (ru) | 2003-02-27 |
EP1265873B1 (de) | 2003-10-15 |
US6624160B2 (en) | 2003-09-23 |
AU2001247224A1 (en) | 2001-10-03 |
HUP0300326A2 (hu) | 2003-07-28 |
IL151787A0 (en) | 2003-04-10 |
EP1265873A2 (de) | 2002-12-18 |
CA2400000A1 (en) | 2001-09-27 |
AR027978A1 (es) | 2003-04-23 |
NO20024502D0 (no) | 2002-09-20 |
EE200200541A (et) | 2004-04-15 |
ES2208581T3 (es) | 2004-06-16 |
PL357443A1 (en) | 2004-07-26 |
NO20024502L (no) | 2002-11-20 |
WO2001070706A3 (en) | 2002-05-10 |
BR0109487A (pt) | 2003-06-10 |
DE60100999T2 (de) | 2004-09-02 |
HK1052694A1 (zh) | 2003-09-26 |
WO2001070706A2 (en) | 2001-09-27 |
CN1406228A (zh) | 2003-03-26 |
ZA200207540B (en) | 2003-12-19 |
ATE252086T1 (de) | 2003-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0105142A3 (en) | 4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | |
EG23232A (en) | Absorbent article. | |
IL144171A0 (en) | Quinolinecarboxamides as antiviral agents | |
MXPA03002269A (es) | Derivados de purina. | |
AU2002221344A1 (en) | Antiviral agents | |
MXPA03002410A (es) | 4-amino-quinazolinas. | |
MXPA03000078A (es) | Derivados de purina. | |
IL161881A (en) | N,n'-substituted-1,3-diamino-2- hydroxypropane derivatives | |
MXPA03000107A (es) | Pirroloquinolonas como agentes antivirales. | |
EG23262A (en) | Delta -pyrrolines. | |
AU6807501A (en) | 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents | |
HK1056872A1 (en) | Indoloquinazolinones. | |
MXPA02005128A (es) | Articulos absorbentes adaptables. | |
MXPA03001877A (es) | 2-guanidin-4-arilquinazolinas. | |
SG116454A1 (en) | Absorbent article. | |
MXPA03005714A (es) | Sulfamidotienopirimidinas. | |
MXPA03002411A (es) | 4-amino-quinazolinas. | |
ZA200206151B (en) | Substituted amionomethyl-phenyl-cyclohexane derivatives. | |
HK1052925A1 (en) | Substituted 1-aminobutan-3-ol derivatives. | |
ZA200205482B (en) | Aminosulfonylbiphenyl derivatives. | |
HK1054037A1 (zh) | 作為抗病毒劑的4-羥基-1,8-二氮雜萘-3-羧酰胺 | |
HK1050890A1 (en) | Aminomethyl -phenyl-cyclohexanone derivatives. | |
HK1054235A1 (zh) | 作為抗病毒藥的4-氧-1,4-二氫[1,8]-二氮雜萘-3-甲酰胺類 | |
IL151787A0 (en) | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents | |
MXPA03002734A (es) | Derivados de 5-amino-1-penten-3-ol sustituidos. |